Flock, smart-money disclosures made readable

Madrigal Pharmaceuticals Inc

MDGLNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−644 sh · $344.7K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−60 sh · $32.0K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−106 sh · $56.6K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−687 sh · $371.4K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−160 sh · $86.0K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−1,202 sh · $652.2K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−512 sh · $272.9K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−131 sh · $69.2K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−505 sh · $272.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−761 sh · $414.6K
Filed 11 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 29 disclosures

REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−368 sh · $199.3K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−1,040 sh · $557.6K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−368 sh · $195.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−120 sh · $65.6K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−218 sh · $116.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−215 sh · $115.9K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−160 sh · $86.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−396 sh · $211.5K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−522 sh · $276.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−362 sh · $196.1K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−1,539 sh · $837.3K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−640 sh · $343.8K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−520 sh · $279.9K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Sibold William John
Madrigal Pharmaceuticals Inc · NASDAQ
−347 sh · $183.7K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Kelley Shannon T
Madrigal Pharmaceuticals Inc · NASDAQ
−664 sh · $341.9K
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Madrigal Pharmaceuticals Inc · NASDAQ
800 sh · $418.8K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Madrigal Pharmaceuticals Inc · NASDAQ
71,870 sh · $37.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Madrigal Pharmaceuticals Inc · NASDAQ
3,920 sh · $2.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Madrigal Pharmaceuticals Inc · NASDAQ
1,427,250 sh · $399.9M
Filed 30 Jun 2024SEC 13Fview source